Immune Systems Advisor

In May 2026, a resurfaced video from the late Vladimir Zelenko (“Dr. Zev” Zelenko) went viral again on X, generating more than 1.5 million views and reigniting debate about zinc, vitamin D, and low-cost antiviral strategies. In the 2-minute clip (video below), Zelenko explains a concept he promoted heavily during the COVID-19 pandemic: many dangerous viruses share the same replication machinery, and therefore may share similar therapeutic vulnerabilities. The video specifically references: COVID-19 Influenza RSV Ebola virus disease Marburg virus disease Hantavirus infections His argument centers on zinc, zinc ionophores, and RNA-dependent RNA polymerase (RdRp), the enzyme many RNA viruses use to replicate. But does the science support the claim? Here’s a balanced, evidence-based review. What Is Hantavirus? Hantaviruses are rodent-borne RNA viruses that can cause severe human disease. Depending on the region and viral strain, infection may lead to: Hantavirus Pulmonary Syndrome (HPS) H...

Ebola Virus Disease (EVD) is a severe, often fatal illness in humans. Historically managed purely through supportive care, the landscape of Ebola virus disease therapeutics has shifted dramatically. Thanks to landmark clinical trials, clinicians now deploy highly targeted, FDA-approved therapies that significantly reduce mortality rates. The Evolution of Ebola Therapeutics: The PALM Trial Benchmark The turning point for modern Ebola virus disease therapeutics occurred during the 2018–2020 outbreak in the Democratic Republic of the Congo. The Pamoja Tulinde Maisha (PALM) randomized controlled trial, published in The New England Journal of Medicine and indexed on PubMed, revolutionized treatment protocols. The PALM trial evaluated four distinct therapeutic candidates. It conclusively demonstrated that targeted monoclonal antibodies offered a vastly superior survival advantage compared to standard care and early antiviral small molecules. FDA-Approved Monoclonal Antibodies for...

Summary The 2026 Ebola outbreak — driven by the rare Bundibugyo strain — is the most serious in years. With over 900 suspected cases, spread into Uganda, an American infected, and both WHO and aid groups warning that response is lagging behind transmission, the situation is escalating rapidly. International measures now include U.S. travel bans, a Kenya quarantine facility, Uganda's border closure, and an emergency vaccine push. Authorities are bracing for a containment effort lasting through the end of 2026. Updated: May 29, 2026 — A fast-moving Bundibugyo Ebola outbreak in the Democratic Republic of Congo (DRC) and Uganda has triggered urgent international action. Over 1,000 suspected cases reported. WHO has declared a Public Health Emergency of International Concern (PHEIC). The United States is establishing an Ebola quarantine facility in Kenya, and Uganda has closed its border with Congo. What Is the Current Ebola Strain and Where Did It Start? The outbreak is caused by th...

Breaking News Analysis | OneDayMD A rapidly evolving Ebola outbreak in Central and East Africa has triggered international concern, emergency travel restrictions, and high-risk medical evacuations involving American healthcare workers treated in Europe under strict isolation protocols. According to multiple reports compiled from global media coverage, the situation is escalating across the Democratic Republic of Congo (DRC) and surrounding regions, with growing fears of cross-border spread and weakening containment capacity. Outbreak Overview: Rare Ebola Strain Driving Regional Alarm The current outbreak is centered in northeastern DRC, with spillover alerts in Uganda and heightened surveillance across neighboring countries. Health authorities have identified the causative agent as the Bundibugyo strain of Ebola virus , a relatively rare subtype associated with significant case fatality rates and limited prior outbreak data. Key reported epidemiologic features include: Dozens of confir...

A fast-spreading Ebola outbreak in the DRC's Ituri province has killed at least 87 people across 246 suspected cases — and experts warn the Bundibugyo strain driving it has no approved vaccine. By One Day MD Editorial Team · Updated May 17, 2026 · 6 min read 87+ Deaths confirmed 246 Suspected cases 13 Lab-confirmed cases 0 Approved vaccines A deadly Ebola outbreak has been confirmed in the Democratic Republic of Congo (DRC), health authorities announced on May 15, 2026 — and it is already spreading beyond the country's borders. At least 87 people have died and 246 suspected cases have been recorded in Ituri province, eastern DRC, making this the country's 17th Ebola outbreak since the virus was first identified there in 1976. What makes this outbreak uniquely alarming is the strain involved. Unlike the majority of Congo's previous outbreaks — which were caused by the well...

Pandemics are not driven by how deadly a virus is — they are driven by how efficiently it spreads, how early it transmits, and how well it evades detection and immunity. This explainer compares Nipah virus, COVID-19 (SARS-CoV-2), Ebola virus, and bird flu (avian influenza such as H5N1 and H7N9) using a systems medicine and preventive health lens . It is designed to answer high-intent search queries such as: Nipah vs COVID vs Ebola vs bird flu Which virus is most dangerous? What is the next pandemic risk? Why some viruses cause pandemics and others don’t The Core Insight: Why Some Viruses Become Pandemics Deadliness alone does not cause pandemics Transmission efficiency outweighs lethality Viruses that spread before symptoms appear dominate globally This framework explains why: COVID-19 reshaped global society Ebola outbreaks remain regional Nipah virus alarms scientists but rarely spreads Bird flu is considered the most credible future pandemic threat Nipah Virus (NiV): High Fatalit...